Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

Table 1 Patients’ characteristics

		N/med [min–max]	Percentage
Patients		285
Sex	Male	191	67
Age at transplant (yo)	Median	49.5 [16–69]
	20–40	87	31
	41–60	157	55
	> 60	41	14
Histological subtype	NOS	110	39
	AITL	83	29
	ALCL ALK+	21	7
	ALCL ALK−	20	7
	ALCL ALK unknown	2	< 1
	ATLL	16	6
	NK/T	16	6
	HSTL	12	4
	EATL	3	1
	LGL	1	< 1
	NK leukemia	1	< 1
Stage at diagnosis	I–II	30	15
	III–IV	172	85
	Missing data	83
Place of alloSCT	Front-line consolidation	138	48
	-CR1	93	33
	-PR1	45	15
	Second-line consolidation	116	41
	-CR2	72	25
	-CR > 2	13	5
	-PR2	25	9
	-PR > 2	6	2
	Progressive disease	31	11
Previous autoSCT	No previous autoSCT	192	67
	Yes (patient in relapse after autoSCT)	66	23
	Yes (tandem auto/alloSCT)	27	9
Karnofsky score at alloSCT	100%	93	35
	90–80%	156	59
	≤ 70%	15	6
	Missing data	21

med median, min minimum, max maximum, yo years old, NOS not otherwise specified, AITL angioimmunoblastic T lymphoma, ALCL anaplastic large cell lymphoma, ALK+/− with/without anaplastic lymphoma kinase mutation, ATLL adult T cell leukemia/lymphoma, NK/T NK/T cell lymphoma, HSTL hepatosplenic T cell lymphoma, EATL enteropathy-associated T cell lymphoma, LGL large granular lymphocyte leukemia, CR complete remission, PR partial remission, SCT stem cell transplantation

ISSN: 1756-8722